Member Info for howdlep

I guess if big pharma want to fund Phase II, would they not want to invest in IQAI rather than just provide funding for the trial?

One thing is for certain, there is NO placing coming as that would be insider dealing.

Trek,

On the face of it, it seems a strange time to be reducing by 2.35m shares (11.26% to 9.97%) given we could be entering a news rich period. However, as I have stated previously, it is my belief that Trevor is considered a 'concert party' to those FAB shares. That means, Trevor could not add to his holding without going over the 30% compulsory offer limit.

Now, however, he could add a further 2.35m shares to his personal IQAI director holding, whilst ensuring FAB has further additional capital.

So my first question is, who has bought the FAB shares? Have they been bought by individuals on the open market, or has Trevor added?

Personally, I doubt Trevor has added yet, as he needs to convert the remaining CLN's first. That is what I would do if I were he.

Going forward, remember the AGM resolution to be able to cancel a percentage of the outstanding shares. Also are we considering ways a third party could invest in IQAI?

All speculation on my part. However, I think things are moving in the background.

Phil

I think one or two people thought Dr Chitambar had died after IQAI's poorly worded tweet yesterday. However, I am pleased to see they added a second tweet four hours later:-

https://twitter.com/IQAI_IB/status/1708893850708627695

@IQAI_IB appreciates Dr. Chitambar's continued involvement in the Ph 1 clinical trial where he is a tremendous mentor and colleague to all. His clinical experience, scientific expertise, and relentless passion to help patients is making a huge impact!

That being the case, I was pleased to add a further 175k (delayed) half an hour ago!

Bidding 4.62p for 350k. Weird you only get 4.6p for tiny.

offering 250k @ 4.67p and 350k @ 4.8p

Last years Letter to Shareholders came out on the 30/9, so I would expect this years to come out today. If we do not get one in the coming days, then maybe the company are about to release another RNS which supersedes the Letter to Shareholders.

What is for certain, is that there are no leaks. So does that indicate a big RNS is pending?

I suspect we will know shortly.

The good thing now is that we have two way liquidity. So anyone who wants to sell can do so, often in size. The giveaway is when the MM's are really on the bid, as the sells go through. Quite simply, they know they will be able to find buyers at a higher price. That said, I think they have been caught out today. More on that, maybe later. Let's see how we end the day.

With a few chunky delayed buys yet to print.

No I very much doubt it, as the CEO has consistently said, in the Finals, that he will continue to be supportive when necessary, via CLN's. Also if I am correct and we have a number of RNS' in the remainder of H2 which are revenue generating, this will not be required. Phase II financing will largely come from a partner.

Following yesterday's profit taking and that 400k sale reported after hours. This is to be expected. However, it's a dangerous traders game to play with news due anytime.

Well those sells have more than evened things up. Let's have some news please Trevor!

Now that's why MM's have been bidding all morning for 375k. A delayed 300k buy at 5.72p has now gone through. Time for us to move up!

Yes good morning. I am certainly hopeful that we will have several revenue generating RNS' over the remainder of H2. That would certainly push the share price a lot higher than current levels. In the meantime, we are likely to have the Letter to Shareholders RNS. Last year, that came out on 30 September.

But MM's happy to take 375k @ 5.665p.

Let's see if one or two buyers come in to make this interesting.

Bid dropped a touch but the reality is you can sell above the mid. Not just a few but 500k @ 5.53p

Oh and it's NT to buy!

Get them when you can imo.

23 September, 2023

Https://www.imagingbiometrics.com/what-we-offer/literature-images/webinars/

Following on from the excellent tweet from Spurs90, which I have commented on:-

Https://twitter.com/howdlep/status/1706561160936337720

"Whilst it is too soon to predict the revenue impact of this new partnership, we are hopeful that it marks a significant expansion of availability globally," said Trevor Brown, CEO of IQ-AI.

Time for that revenue to come through now. Both with Bayer and GE.

Good to see those 4 x 100k buys and the current excellent two way liquidity.

Real spread 5.43 (over mid) v 5.50

Further comments from Zak now out:-

Zak notes we are homing in on the top of the rising trend channel at 6.3p, dating back from January.

Greater than 6.3p on a wk close, targets 10p as soon as the end of October.

He notes the beautiful saucer shape reversal, which has been a slow burner to the upside over the last 2 months.

Https://twitter.com/ZaksTradersCafe/status/1705171789762957529

Kaneonaim pointed out last night the late 500k trade at 5p, timed at 13.29pm on WEDNESDAY. Now if you look at the trades for Wednesday, you will see there were no trades at all between 11.25am and 16.03pm. That is, no buys and no sells. Clearly, they were trying to work that order, but interestingly it was NT to buy for large parts of that 4.5 hour period.

Now roll on to yesterday (Thursday) morning. At 8.42am I posted on here that there was what I would call backwardation (I know that usually relates to anomalies in contract and spot prices) between the bid and offer price. Basically, it was 4.96/4.94 which indicated to me that a MM had a large buy order to fill. That is why I bought the 100k and 75k, as price was obviously going to move up.

So, the question is now, as Kane correctly eluded to, how many other delayed trades have not yet been reported to the market?

MM's have an obligation to disclose when a worked order is complete. Yes they can delay an hour or two I guess, but not a day and a half. So why did they do it?

Today, is going to be very interesting. I remain of the belief that any decent revenue enhancing RNS is going to cause a real spike in the share price. Those of us who are accumulating, will be well rewarded. It is just a matter of time in my opinion. However, this needs to be thought through by all, as gaps in trades leave room for interpretation. My trading strategy, however, remains clear though. GLA.

Liquidity improved a touch for now. Currently 5.21p / 5.38p for 150k

Zak notes the rising trend channel which began with the unfilled gap to the upside through the 50 day line. Now targets 6.5p by the end of next month or sooner, while remaining above Sept resistance at 4.5p. Those who believe that IQAI will be the next big winner, should target 10p over the next month or two. This whilst above 4.5p.

Https://zakstraderscafe.com/bulletin-board-heroes-september-21/7745/